CA-32291/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1985	1
1986	1
1987	2
1988	1
1990	2
1991	1
1992	2
1993	1
2001	1
2002	2
2004	3
2005	1
2006	1
2009	1
2010	2
2024	0

1

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM. Kindler HL, et al. J Clin Oncol. 2010 Aug 1;28(22):3617-22. doi: 10.1200/JCO.2010.28.1386. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606091 Free PMC article. Clinical Trial.

2

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

Adjei AA, Mandrekar SJ, Dy GK, Molina JR, Adjei AA, Gandara DR, Ziegler KL, Stella PJ, Rowland KM Jr, Schild SE, Zinner RG. Adjei AA, et al. J Clin Oncol. 2010 Feb 1;28(4):614-9. doi: 10.1200/JCO.2009.23.6406. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841321 Free PMC article. Clinical Trial.

3

Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies.

Halabi S, Vogelzang NJ, Ou SS, Kelly WK, Small EJ. Halabi S, et al. J Urol. 2006 Jul;176(1):81-6. doi: 10.1016/S0022-5347(06)00566-0. J Urol. 2006. PMID: 16753374

4

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.

Farag SS, Ruppert AS, Mrózek K, Mayer RJ, Stone RM, Carroll AJ, Powell BL, Moore JO, Pettenati MJ, Koduru PR, Stamberg J, Baer MR, Block AW, Vardiman JW, Kolitz JE, Schiffer CA, Larson RA, Bloomfield CD. Farag SS, et al. J Clin Oncol. 2005 Jan 20;23(3):482-93. doi: 10.1200/JCO.2005.06.090. Epub 2004 Nov 8. J Clin Oncol. 2005. PMID: 15534356 Clinical Trial.

5

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).

Otterson GA, Herndon JE 2nd, Watson D, Green MR, Kindler HL; Cancer and Leukemia Group B. Otterson GA, et al. Lung Cancer. 2004 May;44(2):251-9. doi: 10.1016/j.lungcan.2003.10.011. Lung Cancer. 2004. PMID: 15084390 Clinical Trial.

6

Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.

Wetzler M, Dodge RK, Mrózek K, Stewart CC, Carroll AJ, Tantravahi R, Vardiman JW, Larson RA, Bloomfield CD. Wetzler M, et al. Br J Haematol. 2004 Feb;124(3):275-88. doi: 10.1046/j.1365-2141.2003.04736.x. Br J Haematol. 2004. PMID: 14717774 Free article.

7

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Farag SS, Archer KJ, Mrózek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD. Farag SS, et al. Int J Oncol. 2002 Nov;21(5):1041-51. Int J Oncol. 2002. PMID: 12370753

8

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.

Levine EG, Halabi S, Roberts JD, Kaplan EB, Rago R, Atkins JN, Vogelzang NJ. Levine EG, et al. Cancer. 2002 Feb 1;94(3):665-72. doi: 10.1002/cncr.10217. Cancer. 2002. PMID: 11857298 Free article. Clinical Trial.

9

Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

Cameron CL, Cella D, Herndon JE 2nd, Kornblith AB, Zuckerman E, Henderson E, Weiss RB, Cooper MR, Silver RT, Leone L, Canellos GP, Peterson BA, Holland JC. Cameron CL, et al. Health Psychol. 2001 Jan;20(1):71-5. Health Psychol. 2001. PMID: 11199068

10

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

Kornblith AB, Hollis DR, Zuckerman E, Lyss AP, Canellos GP, Cooper MR, Herndon JE 2nd, Phillips CA, Abrams J, Aisner J, et al. Kornblith AB, et al. J Clin Oncol. 1993 Nov;11(11):2081-9. doi: 10.1200/JCO.1993.11.11.2081. J Clin Oncol. 1993. PMID: 8229122 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year